← All organizations
Highest phase reached
Phase 4
First clinical trial
Jul 1, 2002Last known activity
Apr 18, 2025
Timeline
1930s
- Jun 1, 1930
Noordwest Ziekenhuisgroep— Founded
Drugs by trial phase (21 distinct, 15 trials)
Phase 4 (6 own, 0 via acquisition)
Phase 3 (7 own, 0 via acquisition)
Phase 2 (5 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Studied for
- Acute Coronary Syndrome
- Adenocarcinoma
- Angina, Unstable
- Bronchiectasis
- Colonic Neoplasms
- Emphysema
- Esophageal Neoplasms
- Heart Arrest
- Infarction
- Inflammation
- Intermittent Claudication
- Lung Diseases
- Lung Diseases, Obstructive
- Myocardial Infarction
- Non-ST Elevated Myocardial Infarction
- Obesity, Morbid
- Pneumonia
- Pulmonary Disease, Chronic Obstructive
- Pulmonary Emphysema
- Syndrome
- Vomiting
Recent trials (26)
- NCT07146295CollaboratorN/AApr 18, 2025
- NCT04554771CollaboratorPhase 2Nov 1, 2020
- NCT03509662CollaboratorPhase 2Oct 1, 2018
- NCT02657473Overall official - principal investigatorPhase 2/Phase 3Aug 1, 2016
- NCT02657473Lead sponsorPhase 2/Phase 3Aug 1, 2016
- NCT02657473Reponsible party - principal investigatorPhase 2/Phase 3Aug 1, 2016
- NCT02152930Lead sponsorPhase 3Dec 1, 2014
- NCT02152930Overall official - principal investigatorPhase 3Dec 1, 2014
- NCT02152930Reponsible party - principal investigatorPhase 3Dec 1, 2014
- NCT02206256Reponsible party - principal investigatorPhase 4Nov 1, 2014
- NCT02206256Lead sponsorPhase 4Nov 1, 2014
- NCT02231203Lead sponsorPhase 4Oct 1, 2014
- NCT02231203Overall official - principal investigatorPhase 4Oct 1, 2014
- NCT02231203Reponsible party - principal investigatorPhase 4Oct 1, 2014
- NCT02135510CollaboratorPhase 3Jun 1, 2013
Details
- Founded
- Alkmaar, NL Jun 1, 1930
- Last known activity
- Apr 18, 2025